SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Asia PacificEU edition | US edition

Products > Clinical Study

Pycnogenol® Normalizes Cardio Risks During Perimenopause

Format: PDF file | Document type: Clinical Study
Related applications: Cardiovascular health
Luzzi

A new study builds upon previous research showing the benefits of Pycnogenol® for alleviating perimenopause symptoms and is the first study to show effects on cardiovascular risk markers, homocysteine and CRP levels.

Daily Pycnogenol® supplementation reduced and normalized elevated cardiovascular risk factors often related to perimenopause: cholesterol, triglycerides, blood pressure and blood glucose. Participants also reported significant relief of hot flashes, reduction of night sweats and mood improvement.

Related Resources from Horphag Research (USA) Inc.